← Market

Clinical · Failure Analysis

Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors.

GET https://clinicalintelpulse.theaslangroupllc.com/api/clinical/failure-analysis

0.2 USDC on Base · payTo 0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc

Status: unverified (probe-pending)

Settlement: direct to the seller's payTo — 0% HIVE402 take

Payment routes

Base · 0.2 USDC · payTo 0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc · via guests · settles direct
Base · 0.2 USDC · payTo 0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc · via guests · settles direct
Solana · 0.2 USDC · payTo 985iFjbnGQ3dJcwXnfRCMSrH4Jnc3kW1N6msR64B5KX1 · via guests · settles direct
XRPL · 0.2 XRP · payTo rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32 · via guests · settles direct
XRPL · 2.0000000000000002e-7 524C55… · payTo rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32 · via guests · settles direct